Daily FNArena News

A forecast-beating jump in gross margins was the highlight in ResMed’s March quarter result

Governance and social themes, while generally not attracting big expenditure in the December half, still proved a strong focus for corporations

Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements

A negative reaction to Brambles’ March quarter update suggests more was expected, but brokers, while split, are mostly positive

Packaging business Orora continues to struggle in the near term, but brokers agree the company’s prospects in the longer term do look promising

The New Criterion’s Tim Boreham uncovers the potential of 4D Medical in the USA

Companies are expected to ramp up their psychosocial safety strategies following a slew of legislation and legal precedents and ahead of new disclosure standards

Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Bank of Queensland’s result beat forecasts but brokers claim low quality, and line up to retain Sell ratings